Key Background In April 2025, Hims & Hers and Novo Nordisk announced they had partnered to make proven obesity care and treatments more accessible [and] more affordable. At the time, they offered bundled access to online medical care from Hims & Hers and a Wegovy prescription for $599 a month, and said they were developing a roadmap that combines Novo Nordisks innovative medications with Hims & Hers' ability to deliver access to quality care at scale, suggesting the partnership was due to expand to other medications
Get a feel for what appropriate portions and calorie levels look like at your new weight
S., Hahm, K., Jakubowski, A., & Zheng, T
Furthermore, orforglipron patients lost 9.2% of their weight, compared to just 5.3% for oral semaglutide patients
Individuals taking Ozempic after gallbladder removal should monitor their digestive symptoms closely